Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Free Cash Flow (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Free Cash Flow for 16 consecutive years, with -$24.4 million as the latest value for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 656.18% year-over-year to -$24.4 million; the TTM value through Dec 2025 reached -$97.3 million, down 44.36%, while the annual FY2025 figure was -$97.3 million, 44.36% down from the prior year.
  • Free Cash Flow hit -$24.4 million in Q4 2025 for Sangamo Therapeutics, up from -$28.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $11.8 million in Q3 2024 and bottomed at -$77.6 million in Q3 2021.
  • Average Free Cash Flow over 5 years is -$44.5 million, with a median of -$52.5 million recorded in 2021.
  • Year-over-year, Free Cash Flow skyrocketed 119.39% in 2024 and then plummeted 656.18% in 2025.
  • Sangamo Therapeutics' Free Cash Flow stood at -$33.8 million in 2021, then plummeted by 90.73% to -$64.5 million in 2022, then rose by 17.53% to -$53.2 million in 2023, then skyrocketed by 93.93% to -$3.2 million in 2024, then tumbled by 656.18% to -$24.4 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$24.4 million, -$28.6 million, and -$17.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.